1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Sonnet BioTherapeutics Inc (SONN)
  7. Quote


Sonnet BioTherapeutics Stock Price

-0.0028 (-0.44%)
Upgrade to Real-Time
Regular Market
Volume 537,011
Bid Price 0.635
Ask Price 0.637
News -
Day High 0.639899


52 Week Range


Day Low 0.6297
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sonnet BioTherapeutics Inc SONN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0028 -0.44% 0.6361 11:24:07
Open Price Low Price High Price Close Price Prev Close
0.6327 0.6297 0.639899 0.6389
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
602 537,011 $ 0.6333244 $ 340,102 - 0.5508 - 3.415
Last Trade Time Type Quantity Stock Price Currency
11:24:07 100 $ 0.6361 USD


Draw Mode:

Sonnet BioTherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.04M 58.15M 56.95M $ - $ - -6.96 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.60%

more financials information »

Sonnet BioTherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SONN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.64190.670.610.63884953,181,039-0.0058-0.9%
1 Month0.59260.730.59260.65323414,802,4990.04357.34%
3 Months1.032.070.55080.820015311,611,922-0.3939-38.24%
6 Months2.102.730.55080.91082376,013,558-1.46-69.71%
1 Year2.613.4150.55081.133,500,044-1.97-75.63%
3 Years6.2216.200.55082.013,107,087-5.58-89.77%
5 Years6.2216.200.55082.013,107,087-5.58-89.77%

Sonnet BioTherapeutics Description

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Your Recent History
Sonnet Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.